13 sonuç bulundu
Select All
000000000000DEFAULT_TR
by
Yaylak, Bilge, author.
Format:
El Yazması
Alıntı:
Biochemical and functional characterization of circular RNAs differentially expressed in cisplatin
by
Gelmez, Ayşe Bengisu, author.
Format:
El Yazması
Alıntı:
Identification and functional characterization of m6A RNA modifications in cisplatin treated hela
View Other Search Results
3.
by
Kaya, İbrahim, author.
Format:
El Yazması
Alıntı:
Cisplatin.
by
Alkan, Ayşe Hale, author.
Format:
El Yazması
Alıntı:
investigated. Candidate lncRNAs from Doxorubicin, Fas mAB, TNF alpha and Cisplatin treated HeLa cell line were
by
Kara, Merve, author.
Format:
El Yazması
Alıntı:
) and selected as sisRNA candidateS. 48 sisRNA candidates were detected in cisplatin treated data while
by
Yaylak, Bilge, author.
Format:
El Yazması
Alıntı:
/or global circRNAs in apoptotic HeLa cells. Cisplatin (CP), doxorubicin (DOX), Fas mAb(FAS) and TNF
by
Ahmadov, Ulvi, author.
Format:
El Yazması
Alıntı:
%. Under our experimental setting, treatments with cisplatin, doxorubicin, Fas mAb and TNF alpha led to the
by
Gürer, Dilek Cansu, author.
Format:
El Yazması
Alıntı:
, a transcriptomics study was performed under cisplatin, doxorubicin, TNF α and Anti Fas treatments
by
Yarımçam, Murat Caner, author.
Format:
El Yazması
Alıntı:
resemblance between GTF2A 1 antisense lncRNA silencing induced apoptosis and cisplatin induced apoptosis. The
by
Demir, Ayşe Banu, author.
Format:
El Yazması
Alıntı:
. Among these genes, only PDR5 overexpression was found to have cross resistance to Cisplatin. Real time
by
Çiftçi, Yusuf Cem, author.
Format:
El Yazması
Alıntı:
apoptosis in HeLa cells. Additionally, when GTF2A1 AS knockdown was combined with cisplatin, it sensitized
by
Telli, Kübra, author.
Format:
El Yazması
Alıntı:
Cisplatin. The clinical success of these inhibitors requires further examination of potential intrinsic or
13 sonuç bulundu
Arama Sonuçlarını Sınırlandır